9 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... long-acting β2-agonist; ICS ... #Management #Pulmonary ... #LABA #ICS #Guidelines
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... of expiration; ICS ... #Algorithm #Management ... #Pulmonary #LABA ... #ICS #Pharmacology
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
ICS: inhaled corticosteroids ... ; SABA: short-acting ... receptor antagonists; LABA ... #GINA #Asthma #Management ... #Algorithm #Guidelines
LABA/ICS Combination Inhalers
Long-Acting Beta2 Agonists (LABA) + Inhaled Corticosteroid (ICS) - Commonly used in Asthma 
Advair
LABA/ICS Combination ... /ICS combination ... for the COPD treatment ... algorithm). ... Naming #Names #Pharmacology
Myasthenia Gravis Overview

Myasthenia Gravis is an autoimmune disorder of the postsynaptic neuromuscular junction.  Ab to
Clinical Picture ... Bedside: ice pack ... Labs: - AchR antibodies ... immunologic assay - MuSK ... Gravis #diagnosis #management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
lab markers such ... acute coronary syndrome ... #differential #algorithm ... #criticalcare #icu ... #clinical #pharmacology
Multiple Sclerosis - Summary

Multiple Sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system
) is an autoimmune-mediated ... • Or brainstem syndromes ... stimulation Clinical ... sclerosis #diagnosis #management ... #neurology #treatment
There are similarities and differences between these 3 conditions which all carry treatment implications. Each mimic
which all carry treatment ... breakdown of glycogen stores ... for Refeeding Syndrome ... #differential #algorithm ... #management #treatment
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Ocular examination Labs ... salivary ducts Clinical ... phenomenon (16%) MSK ... Adenocarcinoma Treatment ... lubricants • Pharmacologic